Form 8-K - Current report:
SEC Accession No. 0001193125-22-226016
Filing Date
2022-08-22
Accepted
2022-08-22 08:16:03
Documents
14
Period of Report
2022-08-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d364410d8k.htm   iXBRL 8-K 24527
2 EX-99.1 d364410dex991.htm EX-99.1 21149
6 GRAPHIC g364410g0819125004128.jpg GRAPHIC 2957
  Complete submission text file 0001193125-22-226016.txt   182233

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nerv-20220822.xsd EX-101.SCH 2884
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nerv-20220822_lab.xml EX-101.LAB 18758
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nerv-20220822_pre.xml EX-101.PRE 11729
8 EXTRACTED XBRL INSTANCE DOCUMENT d364410d8k_htm.xml XML 3468
Mailing Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

EIN.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36517 | Film No.: 221182258
SIC: 2834 Pharmaceutical Preparations